glp-1 approved for sleep apnea Zepbound's New FDA Approval: What It Means Treating Moderate to Severe GLP1 Drugs Help Protect Against

The search terms used were obesity, OSA, ASP, EDS, CPAP, glucagon-like peptide-1 (GLP-1), GLP-1 receptor (GLP-1R) agonists, liraglutide (LIRA), exenatide (EXE), semaglutide (SEMA), dulaglutide (DULA), sodium-glucose co-transporters 2 (SGLT2) inhibitors, empagliflozin (EMPA), dapagliflozin (DAPA), ertugliflozin (ERTU), canagliflozin (CANA), and luseogliflozin (LUSEO)

Quick Answer: Lightheadedness on tirzepatide typically results from dehydration due to gastrointestinal side effects, hypoglycemia when combined with insulin or sulfonylureas, medication interactions affecting blood pressure, or orthostatic hypotension from weight loss

Most important bioactive compounds secreted by enteroendocrine L cells in the gut due to nutrient uptake are glucagon-like peptides (GLPs) including GLP-1 and GLP-2

Targeting the incretin system [e.g